Kiora Pharmaceuticals CFO Sarah Romano resigns effective Feb 25, 2022

KIORA PHARMACEUTICALS INC

CFO Sarah Romano will resign effective Feb 25, 2022 to pursue another opportunity.
Resignation not due to any disagreement with the Company's operations, policies or practices.
No successor has been announced as of the filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Sarah Romano

Chief Financial Officer

KPRX · KIORA PHARMACEUTICALS INC

Effective: 2022-02-25
Filed: February 14, 2022, 6:59 PM ET

On February 9, 2022, Sarah Romano, the Chief Financial Officer of Kiora Pharmaceuticals, Inc. (the “Company”), notified the Company that she will resign as Chief Financial Officer effective as of February 25, 2022 (the “Effective Date”) to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Sarah Romano resigned as Chief Financial Officer at KIORA PHARMACEUTICALS INC.

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On February 9, 2022, Sarah Romano, the Chief Financial Officer of Kiora Pharmaceuticals, Inc. (the “Company”), notified the Company that she will resign as Chief Financial Officer effective as of February 25, 2022 (the “Effective Date”) to pursue another opportunity.

View on SEC.gov

KIORA PHARMACEUTICALS INC filing history →

Source: SEC EDGAR

accession 0001104659-22-023200

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.